Clinical performance of AI-integrated risk assessment pooling reveals cost savings even at high prevalence of COVID-19

Abstract Individual testing of samples is time- and cost-intensive, particularly during an ongoing pandemic. Better practical alternatives to individual testing can significantly decrease the burden of disease on the healthcare system. Herein, we presented the clinical validation of Segtnan™ on 3929...

Full description

Bibliographic Details
Main Authors: Farzin Kamari, Esben Eller, Mathias Emil Bøgebjerg, Ignacio Martínez Capella, Borja Arroyo Galende, Tomas Korim, Pernille Øland, Martin Lysbjerg Borup, Anja Rådberg Frederiksen, Amir Ranjouriheravi, Ahmed Faris Al-Jwadi, Mostafa Mansour, Sara Hansen, Isabella Diethelm, Marta Burek, Federico Alvarez, Anders Glent Buch, Nima Mojtahedi, Richard Röttger, Eivind Antonsen Segtnan
Format: Article
Language:English
Published: Nature Portfolio 2024-04-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-024-59068-6
_version_ 1797199482003128320
author Farzin Kamari
Esben Eller
Mathias Emil Bøgebjerg
Ignacio Martínez Capella
Borja Arroyo Galende
Tomas Korim
Pernille Øland
Martin Lysbjerg Borup
Anja Rådberg Frederiksen
Amir Ranjouriheravi
Ahmed Faris Al-Jwadi
Mostafa Mansour
Sara Hansen
Isabella Diethelm
Marta Burek
Federico Alvarez
Anders Glent Buch
Nima Mojtahedi
Richard Röttger
Eivind Antonsen Segtnan
author_facet Farzin Kamari
Esben Eller
Mathias Emil Bøgebjerg
Ignacio Martínez Capella
Borja Arroyo Galende
Tomas Korim
Pernille Øland
Martin Lysbjerg Borup
Anja Rådberg Frederiksen
Amir Ranjouriheravi
Ahmed Faris Al-Jwadi
Mostafa Mansour
Sara Hansen
Isabella Diethelm
Marta Burek
Federico Alvarez
Anders Glent Buch
Nima Mojtahedi
Richard Röttger
Eivind Antonsen Segtnan
author_sort Farzin Kamari
collection DOAJ
description Abstract Individual testing of samples is time- and cost-intensive, particularly during an ongoing pandemic. Better practical alternatives to individual testing can significantly decrease the burden of disease on the healthcare system. Herein, we presented the clinical validation of Segtnan™ on 3929 patients. Segtnan™ is available as a mobile application entailing an AI-integrated personalized risk assessment approach with a novel data-driven equation for pooling of biological samples. The AI was selected from a comparison between 15 machine learning classifiers (highest accuracy = 80.14%) and a feed-forward neural network with an accuracy of 81.38% in predicting the rRT-PCR test results based on a designed survey with minimal clinical questions. Furthermore, we derived a novel pool-size equation from the pooling data of 54 published original studies. The results demonstrated testing capacity increase of 750%, 60%, and 5% at prevalence rates of 0.05%, 22%, and 50%, respectively. Compared to Dorfman’s method, our novel equation saved more tests significantly at high prevalence, i.e., 28% (p = 0.006), 40% (p = 0.00001), and 66% (p = 0.02). Lastly, we illustrated the feasibility of the Segtnan™ usage in clinically complex settings like emergency and psychiatric departments.
first_indexed 2024-04-24T07:16:27Z
format Article
id doaj.art-8b205d56f7c44995a2bc9312d4d3f0b4
institution Directory Open Access Journal
issn 2045-2322
language English
last_indexed 2024-04-24T07:16:27Z
publishDate 2024-04-01
publisher Nature Portfolio
record_format Article
series Scientific Reports
spelling doaj.art-8b205d56f7c44995a2bc9312d4d3f0b42024-04-21T11:16:29ZengNature PortfolioScientific Reports2045-23222024-04-0114111510.1038/s41598-024-59068-6Clinical performance of AI-integrated risk assessment pooling reveals cost savings even at high prevalence of COVID-19Farzin Kamari0Esben Eller1Mathias Emil Bøgebjerg2Ignacio Martínez Capella3Borja Arroyo Galende4Tomas Korim5Pernille Øland6Martin Lysbjerg Borup7Anja Rådberg Frederiksen8Amir Ranjouriheravi9Ahmed Faris Al-Jwadi10Mostafa Mansour11Sara Hansen12Isabella Diethelm13Marta Burek14Federico Alvarez15Anders Glent Buch16Nima Mojtahedi17Richard Röttger18Eivind Antonsen Segtnan19Department of Neurophysiology, Institute of Physiology, Eberhard Karls University of TübingenEllergyDepartment of Mathematics and Computer Science, University of Southern DenmarkInnovation Unit, IdISSC, Hospital Clínico San CarlosGrupo de Aplicación de Telecomunicaciones Visuales, Universidad Politécnica de MadridEasyrobotHospital of PsychiatryHospital of PsychiatryHospital of PsychiatryResearch Center for Translational Medicine (KUTTAM), Graduate School of Sciences and Engineering, Koç UniversitySchool of Medicine, University of Southern DenmarkSDU Health Informatics and Technology, Maersk Mc-Kinney Moller Institute, Faculty of Engineering, University of Southern DenmarkSDU Health Informatics and Technology, Maersk Mc-Kinney Moller Institute, Faculty of Engineering, University of Southern DenmarkSDU Health Informatics and Technology, Maersk Mc-Kinney Moller Institute, Faculty of Engineering, University of Southern DenmarkSDU Health Informatics and Technology, Maersk Mc-Kinney Moller Institute, Faculty of Engineering, University of Southern DenmarkGrupo de Aplicación de Telecomunicaciones Visuales, Universidad Politécnica de MadridDepartment of Engineering, Maersk Mc-Kinney Moller Institute, Faculty of Engineering, University of Southern DenmarkDepartment of Neurophysiology, Institute of Physiology, Eberhard Karls University of TübingenDepartment of Mathematics and Computer Science, University of Southern DenmarkDepartment of Neurosurgery, Odense University HospitalAbstract Individual testing of samples is time- and cost-intensive, particularly during an ongoing pandemic. Better practical alternatives to individual testing can significantly decrease the burden of disease on the healthcare system. Herein, we presented the clinical validation of Segtnan™ on 3929 patients. Segtnan™ is available as a mobile application entailing an AI-integrated personalized risk assessment approach with a novel data-driven equation for pooling of biological samples. The AI was selected from a comparison between 15 machine learning classifiers (highest accuracy = 80.14%) and a feed-forward neural network with an accuracy of 81.38% in predicting the rRT-PCR test results based on a designed survey with minimal clinical questions. Furthermore, we derived a novel pool-size equation from the pooling data of 54 published original studies. The results demonstrated testing capacity increase of 750%, 60%, and 5% at prevalence rates of 0.05%, 22%, and 50%, respectively. Compared to Dorfman’s method, our novel equation saved more tests significantly at high prevalence, i.e., 28% (p = 0.006), 40% (p = 0.00001), and 66% (p = 0.02). Lastly, we illustrated the feasibility of the Segtnan™ usage in clinically complex settings like emergency and psychiatric departments.https://doi.org/10.1038/s41598-024-59068-6
spellingShingle Farzin Kamari
Esben Eller
Mathias Emil Bøgebjerg
Ignacio Martínez Capella
Borja Arroyo Galende
Tomas Korim
Pernille Øland
Martin Lysbjerg Borup
Anja Rådberg Frederiksen
Amir Ranjouriheravi
Ahmed Faris Al-Jwadi
Mostafa Mansour
Sara Hansen
Isabella Diethelm
Marta Burek
Federico Alvarez
Anders Glent Buch
Nima Mojtahedi
Richard Röttger
Eivind Antonsen Segtnan
Clinical performance of AI-integrated risk assessment pooling reveals cost savings even at high prevalence of COVID-19
Scientific Reports
title Clinical performance of AI-integrated risk assessment pooling reveals cost savings even at high prevalence of COVID-19
title_full Clinical performance of AI-integrated risk assessment pooling reveals cost savings even at high prevalence of COVID-19
title_fullStr Clinical performance of AI-integrated risk assessment pooling reveals cost savings even at high prevalence of COVID-19
title_full_unstemmed Clinical performance of AI-integrated risk assessment pooling reveals cost savings even at high prevalence of COVID-19
title_short Clinical performance of AI-integrated risk assessment pooling reveals cost savings even at high prevalence of COVID-19
title_sort clinical performance of ai integrated risk assessment pooling reveals cost savings even at high prevalence of covid 19
url https://doi.org/10.1038/s41598-024-59068-6
work_keys_str_mv AT farzinkamari clinicalperformanceofaiintegratedriskassessmentpoolingrevealscostsavingsevenathighprevalenceofcovid19
AT esbeneller clinicalperformanceofaiintegratedriskassessmentpoolingrevealscostsavingsevenathighprevalenceofcovid19
AT mathiasemilbøgebjerg clinicalperformanceofaiintegratedriskassessmentpoolingrevealscostsavingsevenathighprevalenceofcovid19
AT ignaciomartinezcapella clinicalperformanceofaiintegratedriskassessmentpoolingrevealscostsavingsevenathighprevalenceofcovid19
AT borjaarroyogalende clinicalperformanceofaiintegratedriskassessmentpoolingrevealscostsavingsevenathighprevalenceofcovid19
AT tomaskorim clinicalperformanceofaiintegratedriskassessmentpoolingrevealscostsavingsevenathighprevalenceofcovid19
AT pernilleøland clinicalperformanceofaiintegratedriskassessmentpoolingrevealscostsavingsevenathighprevalenceofcovid19
AT martinlysbjergborup clinicalperformanceofaiintegratedriskassessmentpoolingrevealscostsavingsevenathighprevalenceofcovid19
AT anjaradbergfrederiksen clinicalperformanceofaiintegratedriskassessmentpoolingrevealscostsavingsevenathighprevalenceofcovid19
AT amirranjouriheravi clinicalperformanceofaiintegratedriskassessmentpoolingrevealscostsavingsevenathighprevalenceofcovid19
AT ahmedfarisaljwadi clinicalperformanceofaiintegratedriskassessmentpoolingrevealscostsavingsevenathighprevalenceofcovid19
AT mostafamansour clinicalperformanceofaiintegratedriskassessmentpoolingrevealscostsavingsevenathighprevalenceofcovid19
AT sarahansen clinicalperformanceofaiintegratedriskassessmentpoolingrevealscostsavingsevenathighprevalenceofcovid19
AT isabelladiethelm clinicalperformanceofaiintegratedriskassessmentpoolingrevealscostsavingsevenathighprevalenceofcovid19
AT martaburek clinicalperformanceofaiintegratedriskassessmentpoolingrevealscostsavingsevenathighprevalenceofcovid19
AT federicoalvarez clinicalperformanceofaiintegratedriskassessmentpoolingrevealscostsavingsevenathighprevalenceofcovid19
AT andersglentbuch clinicalperformanceofaiintegratedriskassessmentpoolingrevealscostsavingsevenathighprevalenceofcovid19
AT nimamojtahedi clinicalperformanceofaiintegratedriskassessmentpoolingrevealscostsavingsevenathighprevalenceofcovid19
AT richardrottger clinicalperformanceofaiintegratedriskassessmentpoolingrevealscostsavingsevenathighprevalenceofcovid19
AT eivindantonsensegtnan clinicalperformanceofaiintegratedriskassessmentpoolingrevealscostsavingsevenathighprevalenceofcovid19